Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2020-10-13 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 100% confidence The document is a short letter addressed to stock exchanges, providing a certificate under a specific regulation (Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018) for the quarter ended 30th September 2020. It is signed by the company secretary and requests the certificate to be taken on record. The document length is only 1079 characters, indicating it is a brief regulatory communication rather than a full report. There is no financial data or detailed report content, only a certification related to regulatory compliance. According to the rules, such officer certifications or attestations, even if referencing a quarter, should be classified as Regulatory Filings (RNS).
2020-10-13 English
Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company has provided the enclosed certificate for the quarter ended 30th September 2020 under Regulation ....
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, provided by the Registrar and Share Transfer Agent (RTA) for the quarter ended 30th September 2020. It confirms the processing of dematerialisation requests and compliance with SEBI circulars. The document is a regulatory compliance certificate rather than a financial report or announcement of financial results. It is short (2760 characters) and serves as an official attestation or confirmation letter. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance document and not a full report or announcement of financial results or corporate actions.
2020-10-13 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notification to stock exchanges about an upcoming Board of Directors meeting scheduled for 27th October 2020. The purpose of the meeting is to consider unaudited financial results for the quarter and nine months ended 30th September 2020. The document is short (987 characters) and serves as an announcement rather than containing any financial data or results. It is a regulatory announcement pursuant to SEBI regulations informing about the board meeting date and agenda. Therefore, it is best classified as a Regulatory Filing (RNS) rather than an Interim Report (IR) or Earnings Release (ER).
2020-10-13 English
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the ....
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about an upcoming Board of Directors meeting scheduled for 27th October 2020. The purpose of the meeting includes consideration of unaudited financial results for the quarter and nine months ended 30th September 2020. This is a typical announcement made prior to the release of quarterly financial results. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is a notice of a board meeting to consider interim financial results, not the interim report itself. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement under SEBI regulations, rather than an Interim Report (IR) or Earnings Release (ER). The document length is short (987 characters), consistent with a brief announcement rather than a full report.
2020-10-13 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issuance of duplicate share certificates due to lost or misplaced original certificates. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, specifically Regulation 39(3). The content is about share certificate replacement and does not contain financial data, management discussion, voting results, or any report publication. It is an official regulatory announcement related to share certificates but does not fit into categories like Share Issue/Capital Change or Transaction in Own Shares since it deals with duplicate certificates. The best fitting category is Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other specific categories.
2020-10-08 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates ....
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issuance of duplicate share certificates due to lost or misplaced original certificates. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, specifically Regulation 39(3). The content is about share certificate replacement, which is a corporate action related to share capital but does not involve new share issuance or capital structure changes. It is not a financial report, earnings release, or management information. It is also not a director's dealing or major shareholding notification. The closest fitting category is Share Issue/Capital Change (SHA), as it involves changes in share certificates, which falls under capital changes. The document is short and does not contain financial data or report publication announcements, so RPA or RNS are less appropriate. Therefore, the best classification is SHA with high confidence.
2020-10-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.